-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PjeiCRBMf53+Xv/WRq24N0D0/vm2u4PVnHoO0aK/B3IKQHMceEg7TmLePwCAeVNH uJZn0tTxmA/SOgbQn6GWuA== 0001225208-11-008374.txt : 20110303 0001225208-11-008374.hdr.sgml : 20110303 20110303115254 ACCESSION NUMBER: 0001225208-11-008374 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110301 FILED AS OF DATE: 20110303 DATE AS OF CHANGE: 20110303 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BARD C R INC /NJ/ CENTRAL INDEX KEY: 0000009892 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 221454160 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 730 CENTRAL AVE CITY: MURRAY HILL STATE: NJ ZIP: 07974 BUSINESS PHONE: 9082778000 MAIL ADDRESS: STREET 1: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WEILAND JOHN H CENTRAL INDEX KEY: 0001204663 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06926 FILM NUMBER: 11658946 MAIL ADDRESS: STREET 1: C/O C.R BARD INC STREET 2: 730 CENTRAL AVE CITY: MURRAY HILL STATE: NJ ZIP: 07974 4 1 doc4.xml X0303 4 2011-03-01 0000009892 BARD C R INC /NJ/ BCR 0001204663 WEILAND JOHN H C/O C. R. BARD, INC. 730 CENTRAL AVENUE MURRAY HILL NJ 07974 1 1 President and COO Common Stock 2011-03-01 4 S 0 5350.0000 97.8054 D 197878.2900 D Common Stock 2011-03-01 4 S 0 6092.0000 96.8878 D 191786.2900 D Common Stock 5062.8750 I 401(k) Plan Sales are pursuant to a previously disclosed 10b5-1 plan. Represents the weighted average sales price for price increments ranging from $97.54 to $98.03. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Represents the weighted average sales price for price increments ranging from $96.46 to $97.45. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Includes 21.326 shares acquired under the Company's 401(k) Plan from February 4, 2011 to February 28, 2011. Myra McGinley, Attorney-in-Fact 2011-03-03 -----END PRIVACY-ENHANCED MESSAGE-----